Company profile
MLA Diagnostics company profile
MLA Diagnostics is developing the Ly75 indicator, a prognostic biomarker that can effectively predict patients’ clinical outcomes. Moreover, the marker is inexpensive, robust, and efficient. Based on the outcome of the MLA Diagnostics biomarker test, patients and physicians can together choose a more effective and personalised treatment path.
Business identity
- Website
- https://www.mladx.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2019-04-05
Headquarters
- Headquarters
- Maastricht, Limburg, The Netherlands
- Postal code
- 6229 EV
- Country code
- NL
- Continent
- Europe